Series B - Good Therapeutics
Investment Firm
Overview
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Announced Date
Dec 30, 2021
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Digitalis Ventures |
 Roche Venture Fund |
Round Details and Background
Good Therapeutics raised $8000000 on 2021-12-30 in Series B
Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 31, 2019 |  Series A - Good Therapeutics | 4 | - | 11.2M |
| May 07, 2020 | Series A - Good Therapeutics | 5 | - | 11.0M |
| Dec 30, 2021 | Series B - Good Therapeutics | 4 | - | 8.0M |
Recent Activity
There is no recent news or activity for this profile.